Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion type Assertion NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_head.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion wasGeneratedBy ECO_0000203 NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_provenance.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion wasDerivedFrom befree-20140225 NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_provenance.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion SIO_000772 19864236 NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_provenance.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion evidence source_evidence_literature NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_provenance.
- NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868053.RAzbzsQ_9pihTL7RMA3C2sJm_QOSj8YM1fO2h8yl11rAM130_provenance.